Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Phase III, Randomized, Open-Label Study of the Efficacy and Safety of PF-02341066 Versus Standard of Care Chemotherapy (Pemetrexed or Docetaxel) in Pa


Collapse Overview 
Collapse sponsor award id
A8081007 Phase 3 NSCLC


Collapse Biography 

Collapse Time 
Collapse start date
2010-01-27

Collapse end date
2015-01-01